undefined undefined
NaN.000
NaN.00%
Canaccord Genuity analyst Bill Maughan maintains Nkarta (NASDAQ:NKTX) with a Buy and lowers the price target from $16 to $15.
05-11 02:40
Cullinan Therapeutics (NASDAQ:CGEM) drew Wall Street's attention last week as William Blair touted the stock after peer-reviewed data for Amgen's (NASDAQ:AMGN) leukemia therapy, Blincyto, which target...
04-28 03:39
新技术的发展,总是充满令人激动与失望的瞬间。 细胞疗法过去几年的发展便是如此。自然杀伤(NK)细胞疗法因其“通用现货”等优势,被寄予厚望。 作为先天免疫系统的一...
04-15 13:47
Needham:重申Nkarta(NKTX.US)评级,由买入调整至买入评级, 目标价15.00美元。
04-10 19:41
Investors interested in clinical-stage biopharmaceutical companies like Nkarta ...
03-27 02:59
In a report released yesterday, Stephen Willey from Stifel Nicolaus maintained ...
03-26 10:05
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Monday. The Dow traded down 0.37% to 39,331.42 while the NASDAQ rose 0.06% to 16,439.38. The S&P 500 also fell, dropping, 0.12% to 5,227.95.
03-26 03:00
Unity Software(U.US) reported fourth-quarter financial results after the market...
03-26 00:33
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Monday. The Dow traded down 0.22% to 39,389.17 while the NASDAQ fell 0.15% to 16,410.10. The S&P 500 also fell, dropping, 0.16% to 5,226.01.
03-25 23:54
Gainers: Landos Biopharma (LABP) +176%. Altamira Therapeutics (CYTO) +86%. Nkarta (NKTX) +22%. Flora Growth (FLGC) +21%. Sagimet Biosciences (SGMT) +19%. Losers: Nuvation Bio (NUVB) -23%. Autonomix Me...
03-25 22:00